José Vicente Lafuente

Research interests

Publications

• Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome

  Journal of Translational Medicine · 2023 · 10.1186/s12967-023-04678-3

• Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?

  Journal of Translational Medicine · 2022 · 10.1186/s12967-022-03764-2

• Pathophysiology of blood-brain barrier in brain tumor. Novel therapeutic advances using nanomedicine

  International review of neurobiology · 2020 · 10.1016/bs.irn.2020.03.001

• Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation

  Neurobiology of Disease · 2018 · 10.1016/j.nbd.2018.10.001

• Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair

  CNS & Neurological Disorders - Drug Targets · 2016 · 10.2174/1871527315666160819123059

• Intranasal Administration of Chitosan-Coated Nanostructured Lipid Carriers Loaded with GDNF Improves Behavioral and Histological Recovery in a Partial Lesion Model of Parkinson's Disease

  Journal of Biomedical Nanotechnology · 2016 · 10.1166/jbn.2016.2313

• Blood-Brain Barrier Changes in High Altitude

  CNS & Neurological Disorders - Drug Targets · 2016 · 10.2174/1871527315666160920123911

• RETRACTED ARTICLE: Sleep Deprivation-Induced Blood-Brain Barrier Breakdown and Brain Dysfunction are Exacerbated by Size-Related Exposure to Ag and Cu Nanoparticles. Neuroprotective Effects of a 5-HT3 Receptor Antagonist Ondansetron

  Molecular Neurobiology · 2015 · 10.1007/s12035-015-9236-9

• Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson’s disease

  International Journal of Nanomedicine · 2014 · 10.2147/ijn.s61940

• In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson’s disease

  European Journal of Pharmaceutics and Biopharmaceutics · 2013 · 10.1016/j.ejpb.2013.03.034

• Enriched and Deprived Sensory Experience Induces Structural Changes and Rewires Connectivity during the Postnatal Development of the Brain

  Neural Plasticity · 2012 · 10.1155/2012/305693

• Anxiolytic-like effect of losartan injected into amygdala of the acutely stressed rats

  Pharmacological Reports · 2012 · 10.1016/s1734-1140(12)70730-2

• Oxidative stress in Alzheimer's disease hippocampus: A topographical study

  Journal of the Neurological Sciences · 2010 · 10.1016/j.jns.2010.08.029

• Silicon Dioxide Nanoparticles (SiO2, 40–50 nm) Exacerbate Pathophysiology of Traumatic Spinal Cord Injury and Deteriorate Functional Outcome in the Rat. An Experimental Study Using Pharmacological and Morphological Approaches

  Journal of Nanoscience and Nanotechnology · 2009 · 10.1166/jnn.2009.1717

• Effects of Visual Experience on Vascular Endothelial Growth Factor Expression during the Postnatal Development of the Rat Visual Cortex

  Cerebral Cortex · 2007 · 10.1093/cercor/bhm190

• VEGFR-2 expression in brain injury: its distribution related to brain–blood barrier markers

  Journal of Neural Transmission · 2006 · 10.1007/s00702-005-0407-0

• Nϵ-Carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease

  Free Radical Biology and Medicine · 2004 · 10.1016/j.freeradbiomed.2004.02.006

• Expression of Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor Receptor-β (PDGFR-β) in Human Gliomas

  Journal of Molecular Neuroscience · 1999 · 10.1385/jmn:13:1-2:177

• Effects of dark-rearing on the vascularization of the developmental rat visual cortex

  Brain Research · 1996 · 10.1016/0006-8993(96)00485-4

• Traumatic brain injuries: structural changes

  Journal of the Neurological Sciences · 1991 · 10.1016/0022-510x(91)90002-o

Current projects

No projects listed.